Biologic License Application STN BL 125036 - Biogen Alefacept for the Treatment of Chronic Plaque Psoriasis
Dermatologic and Ophthalmic Drugs Advisory Committee Meeting
May 23, 2002
Center for Biologics Evaluation and Research
Next slide
Back to first slide
View graphic version